Antibody Discovery Market Industry Forecast Report 2024-2035, Featuring Ablexis, ChemPartner, Creative Biolabs, GenScript, Genmab, Harbour BioMed, MabSilico, Nona Biosciences, WuXi Biologics and More
16 déc. 2024 13h20 HE
|
Research and Markets
Dublin, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The "Antibody Discovery Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Antibody Discovery Method, Type of Antibody...
FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Forecast to 2034 - Immunovant Advances FcRn Inhibitor Pipeline with Promising Results and FDA Green Light for Pivotal Trial
11 déc. 2024 06h25 HE
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ResearchAndMarkets.com's...
Diagonal Therapeutics to Present Data at ASH 2024 Demonstrating the Economic and Clinical Burden of Hereditary Hemorrhagic Telangiectasia (HHT)
03 déc. 2024 07h00 HE
|
DIAGONAL THERAPEUTICS, INC
Diagonal Therapeutics to Present Data at ASH 2024 Demonstrating the Economic and Clinical Burden of Hereditary Hemorrhagic Telangiectasia (HHT)
Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report 2025-2030, Featuring Laboratory Corporation of America, IQVIA, Syneous Health, SGS, WuXi AppTec and Other Major Players
02 déc. 2024 04h56 HE
|
Research and Markets
Dublin, Dec. 02, 2024 (GLOBE NEWSWIRE) -- The "Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis, 2025-2030" report has been added to ResearchAndMarkets.com's...
Monoclonal Antibody Collaboration and Licensing Analysis Report 2024 with Directory of 639 Deals Signed Since 2019 by Company A-Z, Deal Type and Therapeutic Target
26 nov. 2024 06h29 HE
|
Research and Markets
Dublin, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The "Monoclonal Antibody Collaboration and Licensing Deals 2019-2024" report has been added to ResearchAndMarkets.com's offering. Fully revised and...
Lyophilization Services for Biopharmaceuticals Industry Research Report 2024-2033: Drivers and Restraints, Competitive Landscape, Future Opportunities and Strategies
22 nov. 2024 06h47 HE
|
Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Lyophilization Services for Biopharmaceuticals Market Opportunities and Strategies to 2033" report has been added to ResearchAndMarkets.com's...
Numab Therapeutics and Kaken Pharmaceutical Enter Collaboration and Option Agreement for Multi-specific Antibody ND081 for Treatment of Inflammatory Bowel Disease
15 nov. 2024 04h30 HE
|
Numab Therapeutics AG; Kaken Pharmaceutical Co., Ltd.
Numab to receive R&D funding for the preclinical development of ND081 Kaken Pharmaceutical receives an option to in-license ND081 in certain Asian territories in exchange for funding global...
CC Chemokine Receptor Type 5 Market Research Report 2024
07 nov. 2024 09h35 HE
|
Research and Markets
Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC chemokine receptor type 5 market...
Numab Therapeutics Announces Initiation of Phase 1 Clinical Study of NM32 Program in Patients with Solid Tumors
30 oct. 2024 08h00 HE
|
Numab Therapeutics AG
NM32 is a first-in-class half-life-enhanced T-cell engager targeting ROR1, a tumor associated antigen with broad expression in solid tumors and hematological malignancies Low molecular...
Australia & New Zealand Research Antibodies Market Report 2024-2030, with Leading Players Abcam, BD, Merck, Lonza, Cell Signaling Technology, F. Hoffmann-La Roche, Agilent Technologies, Revvity & More
14 oct. 2024 07h41 HE
|
Research and Markets
Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) -- The "Australia & New Zealand Research Antibodies Market Size, Share and Trends Analysis Report by Product, Specificity, Technology, Source, Application,...